{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:38:48Z","timestamp":1792625928239,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yuelushan Laboratory Breeding Program","award":["YLS-2025-ZY04057"],"award-info":[{"award-number":["YLS-2025-ZY04057"]}]},{"name":"National Key R&D Program of China","award":["2021YFD1600301"],"award-info":[{"award-number":["2021YFD1600301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Sci Food"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The ancient text \u201cCompendium of Materia Medica\u201d records that\n                    <jats:italic>Hemerocallis citrina<\/jats:italic>\n                    Baroni (daylily) was used for antidepressant, but its active components and mechanisms remain unknown. In this study, the\n                    <jats:italic>H. citrina<\/jats:italic>\n                    extract was initially fractionated into three parts, and only the 35% HCW (35% ethanol-eluted fraction of\n                    <jats:italic>Hemerocallis citrina<\/jats:italic>\n                    water extract, LILYANTIDEPRES\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ) demonstrated significant antidepressant activity, notably increasing the levels of dopamine (DA), norepinephrine (NE), and brain-derived neurotrophic factor (BDNF) in the brain of depressed mice. It\u2019s also significantly reducing the IL-6 (Interleukin-6) and MDA (Malondialdehyde) levels, and improving the gut microbiota. The main components of the 35% HCW were identified as 3-\n                    <jats:italic>O-<\/jats:italic>\n                    p-coumaroylquinic acid (\n                    <jats:bold>1<\/jats:bold>\n                    ) and 4-\n                    <jats:italic>O-<\/jats:italic>\n                    p-coumaroylquinic acid (\n                    <jats:bold>2<\/jats:bold>\n                    ), which were also chemically synthesized. Both compounds exhibited significant antidepressant activity by increasing the levels of DA, NE, and BDNF in the brain of depressed mice and significantly reducing the levels of IL-6 and TNF-\u03b1 (Tumor Necrosis Factor-\u03b1). A potential mechanism to elevate DA and NE levels in the depressed mice brain via the CA (coumaroylquinic acid)\/Dopa\/DA\/NE pathway. Additionally, compounds\n                    <jats:bold>1<\/jats:bold>\n                    and\n                    <jats:bold>2<\/jats:bold>\n                    significantly increase BDNF levels through the PKA (Protein Kinase A)\/CREB (cAMP Response Element-Binding Protein)\/BDNF signaling pathway. This study provides the first elucidation of the antidepressant components of\n                    <jats:italic>H. citrina<\/jats:italic>\n                    and the mechanisms, laying the foundation for the development of antidepressant products and the high-value utilization of\n                    <jats:italic>H. citrina<\/jats:italic>\n                    resources.\n                  <\/jats:p>","DOI":"10.1038\/s41538-026-00934-0","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:51:34Z","timestamp":1782913894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["3-O-p-coumaroylquinic acid and 4-O-p-coumaroylquinic acid from Hemerocallis citrina Baroni exert antidepressant effects via CA\/Dopa\/DA\/NE and PKA\/CREB\/BDNF signaling pathways"],"prefix":"10.1038","volume":"10","author":[{"given":"Faying","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jad.2024.07.062","volume":"362","author":"L Corneliusson","year":"2024","unstructured":"Corneliusson, L., Gustafson, Y. & Olofsson, B. Prevalence of depressive disorders among the very old in the 21st century. J. Affect Disord. 362, 706\u2013715 (2024).","journal-title":"J. Affect Disord."},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJMra2033475","volume":"385","author":"L Miller","year":"2021","unstructured":"Miller, L. & Campo, J. V. Depression in adolescents. N. Engl. J. Med. 385, 445\u2013449 (2021).","journal-title":"N. Engl. J. Med."},{"key":"934_CR3","unstructured":"World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. CC BY-NC-SA 3.0 IGO (World Health Organization, 2017)."},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris, R. et al. Trial of psilocybin versus escitalopram for depression. N. Engl. J. Med. 384, 1402\u20131411 (2021).","journal-title":"N. Engl. J. Med."},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","volume":"23","author":"TM Hillhouse","year":"2015","unstructured":"Hillhouse, T. M. & Porter, J. H. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp. Clin. Psychopharmacol. 23, 1\u201321 (2015).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.dcmed.2023.02.001","volume":"6","author":"YE Tian","year":"2023","unstructured":"Tian, Y. E. et al. Antidepressant-like active ingredients and their related mechanisms of functional foods or medicine and food homologous products. Digit. Chin. Med. 6, 9\u201327 (2023).","journal-title":"Digit. Chin. Med."},{"key":"934_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.70483","volume":"90","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. Laxative ingredients of fresh Hemerocallis citrina baroni. J. Food Sci. 90, e70483 (2025).","journal-title":"J. Food Sci."},{"key":"934_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1431856","volume":"15","author":"J Fang","year":"2024","unstructured":"Fang, J. et al. Lactation-promoting ingredients of Hemerocallis citrina Borani and the corresponding mechanisms. Front. Pharm. 15, 1431856 (2024).","journal-title":"Front. Pharm."},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41438-021-00539-6","volume":"8","author":"Z Qing","year":"2021","unstructured":"Qing, Z. et al. The chromosome-level Hemerocallis citrina Borani genome provides new insights into the rutin biosynthesis and the lack of colchicine. Hortic. Res. 8, 89 (2021).","journal-title":"Hortic. Res."},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jep.2011.11.059","volume":"139","author":"L Gu","year":"2012","unstructured":"Gu, L., Liu, Y. J., Wang, Y. B. & Yi, L. T. Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina. J. Ethnopharmacol. 139, 780\u2013787 (2012).","journal-title":"J. Ethnopharmacol."},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jep.2012.09.016","volume":"144","author":"LT Yi","year":"2012","unstructured":"Yi, L. T. et al. Ethanol extracts from Hemerocallis citrina attenuate the decreases of brain-derived neurotrophic factor, TrkB levels in rat induced by corticosterone administration. J. Ethnopharmacol. 144, 328\u2013334 (2012).","journal-title":"J. Ethnopharmacol."},{"key":"934_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.967670","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Antidepressant-like activity, active components and related mechanism of Hemerocallis citrina Baroni extracts. Front. Pharm. 13, 967670 (2022).","journal-title":"Front. Pharm."},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/2225-4110.106548","volume":"3","author":"SH Lin","year":"2013","unstructured":"Lin, S. H. et al. The antidepressant-like effect of ethanol extract of daylily flowers (J\u012bn Zh\u0113n Hu\u0101) in rats. J. Tradit. Complement. Med. 3, 53\u201361 (2013).","journal-title":"J. Tradit. Complement. Med."},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1472-6882-14-326","volume":"14","author":"B Du","year":"2014","unstructured":"Du, B. et al. Antidepressant-like effects of the hydroalcoholic extracts of Hemerocallis citrina and its potential active components. BMC Complement. Alter. Med. 14, 326 (2014).","journal-title":"BMC Complement. Alter. Med."},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jep.2014.03.001","volume":"153","author":"XL Liu","year":"2014","unstructured":"Liu, X. L. et al. Ethanol extracts from Hemerocallis citrina attenuate the upregulation of proinflammatory cytokines and indoleamine 2,3-dioxygenase in rats. J. Ethnopharmacol. 153, 484\u2013490 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jep.2016.09.023","volume":"194","author":"P Xu","year":"2016","unstructured":"Xu, P. et al. Antidepressant-like effects and cognitive enhancement of the total phenols extract of Hemerocallis citrina Baroni in chronic unpredictable mild stress rats and its related mechanism. J. Ethnopharmacol. 194, 819\u2013826 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"934_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.974949","volume":"13","author":"Z Dong","year":"2022","unstructured":"Dong, Z. et al. Neferine alleviates chronic stress-induced depression by regulating monoamine neurotransmitter secretion and gut microbiota structure. Front. Pharm. 13, 974949 (2022).","journal-title":"Front. Pharm."},{"key":"934_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2024.114616","volume":"284","author":"Z Mao","year":"2024","unstructured":"Mao, Z. et al. Antidepressant-like effects of Cimicifuga dahurica (Turcz.) maxim. via modulation of monoamine regulatory pathways. Physiol. Behav. 284, 114616 (2024).","journal-title":"Physiol. Behav."},{"key":"934_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1544795","volume":"16","author":"A Zelek-Molik","year":"2025","unstructured":"Zelek-Molik, A. & Litwa, E. Trends in research on novel antidepressant treatments. Front. Pharm. 16, 1544795 (2025).","journal-title":"Front. Pharm."},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui, L. et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct. Target Ther. 9, 30 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"934_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.112005","volume":"214","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Role of PKA\/CREB\/BDNF signaling in PM2.5-induced neurodevelopmental damage to the hippocampal neurons of rats. Ecotoxicol. Environ. Saf. 214, 112005 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"14627","DOI":"10.1007\/s12035-025-05001-5","volume":"62","author":"AK Gupta","year":"2025","unstructured":"Gupta, A. K. et al. Exploring the connection between BDNF\/TrkB and AC\/cAMP\/PKA\/CREB signaling pathways: potential for neuroprotection and therapeutic targets for neurological disorders. Mol. Neurobiol. 62, 14627\u201314659 (2025).","journal-title":"Mol. Neurobiol."},{"key":"934_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122282","volume":"336","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury. Life Sci. 336, 122282 (2024).","journal-title":"Life Sci."},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/STROKEAHA.124.048697","volume":"56","author":"X Yang","year":"2025","unstructured":"Yang, X. et al. Intermittent theta burst stimulation over cerebellum facilitates neurological recovery in poststroke depression via the cAMP\/PKA\/CREB pathway. Stroke 56, 1266\u20131279 (2025).","journal-title":"Stroke"},{"key":"934_CR25","first-page":"790","volume":"17","author":"M Huang","year":"2025","unstructured":"Huang, M. et al. Jiaotaiwan activates serum SCFAs and upregulates cAMP-PKA-CREB-BDNF signaling pathway for antidepressant effects: a multicenter, randomized, controlled study. Chin. Herb. Med. 17, 790\u2013797 (2025).","journal-title":"Chin. Herb. Med."},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41586-022-04396-8","volume":"602","author":"BD Needham","year":"2022","unstructured":"Needham, B. D. et al. A gut-derived metabolite alters brain activity and anxiety behaviour in mice. Nature 602, 647\u2013653 (2022).","journal-title":"Nature"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.apsb.2022.02.032","volume":"12","author":"ZW Zhang","year":"2022","unstructured":"Zhang, Z. W. et al. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota. Acta Pharm. Sin. B 12, 3298\u20133312 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1871527321666220329140804","volume":"22","author":"S Bhatt","year":"2023","unstructured":"Bhatt, S. et al. Role of brain-gut-microbiota axis in depression: emerging therapeutic avenues. CNS Neurol. Disord. Drug Targets 22, 276\u2013288 (2023).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"934_CR30","doi-asserted-by":"publisher","unstructured":"Chudzik, A., Orzy\u0142owska, A., Rola, R. & Stanisz, G. J. Probiotics, prebiotics and postbiotics on mitigation of depression symptoms: modulation of the brain-gut-microbiome axis. Biomolecules 11, https:\/\/doi.org\/10.3390\/biom11071000 (2021).","DOI":"10.3390\/biom11071000"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais, L. H., Schreiber, H. L. T. & Mazmanian, S. K. The gut microbiota-brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. 19, 241\u2013255 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"934_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414792","volume":"12","author":"Y He","year":"2025","unstructured":"He, Y. et al. Dimethyl itaconate alleviates Escherichia coli-induced endometritis through the guanosine-CXCL14 axis via increasing the abundance of norank_f_Muribaculaceae. Adv. Sci. 12, e2414792 (2025).","journal-title":"Adv. Sci."},{"key":"934_CR33","doi-asserted-by":"publisher","unstructured":"Zhu, Y. et al. Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function. Nutrients 16, https:\/\/doi.org\/10.3390\/nu16162660 (2024).","DOI":"10.3390\/nu16162660"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4236\/nm.2017.84008","volume":"08","author":"M Chen","year":"2017","unstructured":"Chen, M. & Russo-Neustadt, A. Norepinephrine induces BDNF and activates CREB and discriminates among protein kinase C isoforms in cultured embryonic hippocampal neurons. Neurosci. Med. 08, 53\u201367 (2017).","journal-title":"Neurosci. Med."},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11064-024-04293-8","volume":"50","author":"OB Rivera-Maya","year":"2024","unstructured":"Rivera-Maya, O. B., Ortiz-Robles, C. D., Palacios-Valladares, J. R. & Calder\u00f3n-Aranda, E. S. Dopamine D1-like receptor stimulation induces CREB, Arc, and BDNF dynamic changes in differentiated SH-SY5Y cells. Neurochem. Res. 50, 35 (2024).","journal-title":"Neurochem. Res."},{"key":"934_CR36","doi-asserted-by":"publisher","unstructured":"Ma, T. et al. An investigation of the anti-depressive properties of phenylpropanoids and flavonoids in Hemerocallis citrina Baroni. Molecules 27, https:\/\/doi.org\/10.3390\/molecules27185809 (2022).","DOI":"10.3390\/molecules27185809"},{"key":"934_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1642515","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Hemerocallis citrina Baroni leaf total phenol alleviates depressive-like behaviors via modulating \u201cmicrobiota-gut-brain\u201d axis in chronic unpredictable mild stress -induced rats. Front. Pharm. 16, 1642515 (2025).","journal-title":"Front. Pharm."},{"key":"934_CR38","doi-asserted-by":"publisher","unstructured":"Gao, S. et al. Revealing the mechanism of Hemerocallis citrina Baroni in depression treatment through integrated network pharmacology and transcriptomic analysis. Pharmaceuticals 17, https:\/\/doi.org\/10.3390\/ph17121704 (2024).","DOI":"10.3390\/ph17121704"},{"key":"934_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1370619","volume":"15","author":"Y Jia","year":"2024","unstructured":"Jia, Y. et al. Neuroprotective effects of total phenolics from Hemerocallis citrina Baroni leaves through the PI3K\/AKT pathway. Front. Pharm. 15, 1370619 (2024).","journal-title":"Front. Pharm."},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","volume":"90","author":"E Castr\u00e9n","year":"2021","unstructured":"Castr\u00e9n, E. & Monteggia, L. M. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol. Psychiatry 90, 128\u2013136 (2021).","journal-title":"Biol. Psychiatry"},{"key":"934_CR41","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41380-024-02625-2","volume":"29","author":"CE Page","year":"2024","unstructured":"Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A. & Thompson, S. M. Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Mol. Psychiatry 29, 3802\u20133813 (2024).","journal-title":"Mol. Psychiatry"},{"key":"934_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02921-z","volume":"14","author":"S Poletti","year":"2024","unstructured":"Poletti, S., Mazza, M. G. & Benedetti, F. Inflammatory mediators in major depression and bipolar disorder. Transl. Psychiatry 14, 247 (2024).","journal-title":"Transl. Psychiatry"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto, P. C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184, 1299\u20131313.e1219 (2021).","journal-title":"Cell"},{"key":"934_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105159","volume":"149","author":"D Cavaleri","year":"2023","unstructured":"Cavaleri, D. et al. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: insight from meta-analyses. Neurosci. Biobehav. Rev. 149, 105159 (2023).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"111143","DOI":"10.1016\/j.brainresbull.2024.111143","volume":"220","author":"Y Fan","year":"2025","unstructured":"Fan, Y. et al. Exploring the association between BDNF related signaling pathways and depression: a literature review. Brain Res. Bull. 220, 111143 (2025).","journal-title":"Brain Res. Bull."},{"key":"934_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2023.114415","volume":"273","author":"Y Cao","year":"2024","unstructured":"Cao, Y. et al. Protection of p-coumaric acid against chronic stress-induced neurobehavioral deficits in mice via activating the PKA-CREB-BDNF pathway. Physiol. Behav. 273, 114415 (2024).","journal-title":"Physiol. Behav."},{"key":"934_CR47","doi-asserted-by":"publisher","unstructured":"Yu, X. D. et al. P-coumaric acid reverses depression-like behavior and memory deficit via inhibiting AGE-RAGE-mediated neuroinflammation. Cells 11, https:\/\/doi.org\/10.3390\/cells11101594 (2022).","DOI":"10.3390\/cells11101594"},{"key":"934_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154871","volume":"116","author":"DR Oh","year":"2023","unstructured":"Oh, D. R. et al. Antidepressant effects of p-coumaric acid isolated from Vaccinium bracteatum leaves extract on chronic restraint stress mouse model and antagonism of serotonin 6 receptor in vitro. Phytomedicine 116, 154871 (2023).","journal-title":"Phytomedicine"},{"key":"934_CR49","first-page":"356","volume":"18","author":"M Guven","year":"2015","unstructured":"Guven, M. et al. Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia. Iran. J. Basic Med. Sci. 18, 356\u2013363 (2015).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41583-024-00876-0","volume":"26","author":"C Liao","year":"2025","unstructured":"Liao, C., Dua, A. N., Wojtasiewicz, C., Liston, C. & Kwan, A. C. Structural neural plasticity evoked by rapid-acting antidepressant interventions. Nat. Rev. Neurosci. 26, 101\u2013114 (2025).","journal-title":"Nat. Rev. Neurosci."},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","volume":"185","author":"CS Wang","year":"2022","unstructured":"Wang, C. S., Kavalali, E. T. & Monteggia, L. M. BDNF signaling in context: from synaptic regulation to psychiatric disorders. Cell 185, 62\u201376 (2022).","journal-title":"Cell"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.euroneuro.2024.06.008","volume":"87","author":"CA Madsen","year":"2024","unstructured":"Madsen, C. A. et al. The effect of antidepressant treatment on blood BDNF levels in depressed patients: a review and methodological recommendations for assessment of BDNF in blood. Eur. Neuropsychopharmacol. 87, 35\u201355 (2024).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41420-024-01974-9","volume":"10","author":"Y Ruan","year":"2024","unstructured":"Ruan, Y. et al. New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity. Cell Death Discov. 10, 205 (2024).","journal-title":"Cell Death Discov."},{"key":"934_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02902-2","volume":"14","author":"FM Daray","year":"2024","unstructured":"Daray, F. M. et al. Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case-control study. Transl. Psychiatry 14, 254 (2024).","journal-title":"Transl. Psychiatry"},{"key":"934_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03532-y","volume":"15","author":"RG Nava","year":"2025","unstructured":"Nava, R. G. et al. Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation. Transl. Psychiatry 15, 314 (2025).","journal-title":"Transl. Psychiatry"},{"key":"934_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03738-0","volume":"16","author":"Z Dong","year":"2025","unstructured":"Dong, Z. et al. Circulating inflammatory proteins associated with risks of schizophrenia, bipolar disorder, and major depressive disorder: a Mendelian randomization study. Transl. Psychiatry 16, 3 (2025).","journal-title":"Transl. Psychiatry"},{"key":"934_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41579-024-01136-9","volume":"23","author":"TE Ohara","year":"2025","unstructured":"Ohara, T. E. & Hsiao, E. Y. Microbiota-neuroepithelial signaling across the gut-brain axis. Nat. Rev. Microbiol. 23, 371\u2013384 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.biopsych.2023.08.020","volume":"95","author":"AJ McGuinness","year":"2024","unstructured":"McGuinness, A. J., Loughman, A., Foster, J. A. & Jacka, F. Mood disorders: the gut bacteriome and beyond. Biol. Psychiatry 95, 319\u2013328 (2024).","journal-title":"Biol. Psychiatry"},{"key":"934_CR59","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1038\/s41380-025-03191-x","volume":"30","author":"L Liu","year":"2025","unstructured":"Liu, L. et al. The emerging role of the gut microbiome in depression: implications for precision medicine. Mol. Psychiatry 30, 5901\u20135913 (2025).","journal-title":"Mol. Psychiatry"},{"key":"934_CR60","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/s41380-025-03345-x","volume":"31","author":"L Liu","year":"2026","unstructured":"Liu, L. et al. Mapping the reciprocal interactions between antidepressants and the gut microbiome: novel targets for the personalisation and optimization of drug response. Mol. Psychiatry 31, 1992\u20132004 (2026).","journal-title":"Mol. Psychiatry"},{"key":"934_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101741","volume":"5","author":"JA Foster","year":"2024","unstructured":"Foster, J. A. & Trivedi, M. H. The gut-brain axis in depression: are multi-omics showing the way? Cell Rep. Med. 5, 101741 (2024).","journal-title":"Cell Rep. Med."},{"key":"934_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03504-2","volume":"15","author":"SM Jabbari Shiadeh","year":"2025","unstructured":"Jabbari Shiadeh, S. M. et al. Bidirectional crosstalk between the gut microbiota and cellular compartments of brain: implications for neurodevelopmental and neuropsychiatric disorders. Transl. Psychiatry 15, 278 (2025).","journal-title":"Transl. Psychiatry"},{"key":"934_CR63","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/s41380-025-03398-y","volume":"31","author":"A Tang","year":"2026","unstructured":"Tang, A. et al. Gut microbiota modulates synaptic plasticity, connectivity, and dopamine transmission in the VTA-mPFC pathway in bipolar depression. Mol. Psychiatry 31, 2589\u20132604 (2026).","journal-title":"Mol. Psychiatry"},{"key":"934_CR64","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1038\/s41380-025-03000-5","volume":"30","author":"D Wang","year":"2025","unstructured":"Wang, D. et al. PsycGM: a comprehensive database for associations between gut microbiota and psychiatric disorders. Mol. Psychiatry 30, 4222\u20134233 (2025).","journal-title":"Mol. Psychiatry"},{"key":"934_CR65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41386-023-01625-0","volume":"49","author":"TM Gyles","year":"2024","unstructured":"Gyles, T. M., Nestler, E. J. & Parise, E. M. Advancing preclinical chronic stress models to promote therapeutic discovery for human stress disorders. Neuropsychopharmacology 49, 215\u2013226 (2024).","journal-title":"Neuropsychopharmacology"}],"container-title":["npj Science of Food"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00934-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:59:06Z","timestamp":1792623546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41538-026-00934-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1038\/s41538-026-00934-0","relation":{},"ISSN":["2396-8370"],"issn-type":[{"value":"2396-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"323"}}